CD274 and digestive system neoplasm: For instance, immunotherapy using the anti-PDL1 antibody in combination with a vaccine revealed evidence of safety, induction of a stronger immunological response, and the suppression of gastrointestinal tumors compared to those that received the anti-PDL1 treatment or the vaccine only [27,29].